Log in to save to my catalogue

A phase IIb randomized placebo-controlled trial testing the effect of MAG-EPA long-chain omega-3 fat...

A phase IIb randomized placebo-controlled trial testing the effect of MAG-EPA long-chain omega-3 fat...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8fa08d5461164138b62c488895322ad6

A phase IIb randomized placebo-controlled trial testing the effect of MAG-EPA long-chain omega-3 fatty acid dietary supplement on prostate cancer proliferation

About this item

Full title

A phase IIb randomized placebo-controlled trial testing the effect of MAG-EPA long-chain omega-3 fatty acid dietary supplement on prostate cancer proliferation

Publisher

London: Nature Publishing Group UK

Journal title

Communications medicine, 2024-03, Vol.4 (1), p.56-11, Article 56

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Background
High prostate eicosapentaenoic fatty acid (EPA) levels were associated with a significant reduction of upgrading to grade group (GG) ≥ 2 prostate cancer in men under active surveillance. We aimed to evaluate the effect of MAG-EPA long-chain omega-3 fatty acid dietary supplement on prostate cancer proliferation.
Methods
A phase I...

Alternative Titles

Full title

A phase IIb randomized placebo-controlled trial testing the effect of MAG-EPA long-chain omega-3 fatty acid dietary supplement on prostate cancer proliferation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8fa08d5461164138b62c488895322ad6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8fa08d5461164138b62c488895322ad6

Other Identifiers

ISSN

2730-664X

E-ISSN

2730-664X

DOI

10.1038/s43856-024-00456-4

How to access this item